Leya Y Schwartz

Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations

T. Bowman, K. Pradhan, Amit Verma, 2022, bioRxiv.

Preclinical Activity of the Clinical Stage Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor PRT543 in Splicing Mutant Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

A. Verma, P. Scherle, S. Sahu, 2021, Blood.

Role of IL8 in myeloid malignancies

U. Steidl, B. Will, A. Shastri, 2023, Leukemia & lymphoma.

Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activation

M. Weirauch, K. Pradhan, N. Salomonis, 2024, bioRxiv.